NeurogesX replaces DiTonno with Martell
This article was originally published in Scrip
Executive Summary
San Mateo, California-based NeurogesX, which is focused on developing and commercialising pain management therapies, has appointed Ronald Martell as president and CEO. Prior to joining NeurogesX, Mr Martell was CEO at Poniard Pharmaceuticals. He replaces Tony DiTonno, who has retired.